HUP9802940A2 - Kinolin-2(1H)-on-származékok mint szerotoninantagonisták - Google Patents

Kinolin-2(1H)-on-származékok mint szerotoninantagonisták

Info

Publication number
HUP9802940A2
HUP9802940A2 HU9802940A HUP9802940A HUP9802940A2 HU P9802940 A2 HUP9802940 A2 HU P9802940A2 HU 9802940 A HU9802940 A HU 9802940A HU P9802940 A HUP9802940 A HU P9802940A HU P9802940 A2 HUP9802940 A2 HU P9802940A2
Authority
HU
Hungary
Prior art keywords
quinoline
derivatives
serotonin antagonists
serotonin
antagonists
Prior art date
Application number
HU9802940A
Other languages
English (en)
Inventor
Michel Aletru
Genevieve Dellac
Christian Hoornaert
Gary Mccort
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510815A external-priority patent/FR2738822B1/fr
Priority claimed from FR9511083A external-priority patent/FR2739100B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of HUP9802940A2 publication Critical patent/HUP9802940A2/hu
Publication of HUP9802940A3 publication Critical patent/HUP9802940A3/hu
Publication of HU222745B1 publication Critical patent/HU222745B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9802940A 1995-09-15 1996-09-12 Kinolin-2(1H)-on-származékok mint szerotonin antagonisták, elżállításuk és alkalmazásuk HU222745B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510815A FR2738822B1 (fr) 1995-09-15 1995-09-15 Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR9511083A FR2739100B1 (fr) 1995-09-21 1995-09-21 Derives de 4-(omega-(4-(4-fluorobenzoyl)piperidin-1-yl)- alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
PCT/FR1996/001401 WO1997010238A1 (fr) 1995-09-15 1996-09-12 Derives de quinolein-2(1h)-one comme antagonistes de la serotonine

Publications (3)

Publication Number Publication Date
HUP9802940A2 true HUP9802940A2 (hu) 1999-05-28
HUP9802940A3 HUP9802940A3 (en) 2001-11-28
HU222745B1 HU222745B1 (hu) 2003-09-29

Family

ID=26232206

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802940A HU222745B1 (hu) 1995-09-15 1996-09-12 Kinolin-2(1H)-on-származékok mint szerotonin antagonisták, elżállításuk és alkalmazásuk

Country Status (30)

Country Link
US (1) US5958924A (hu)
EP (1) EP0850235B1 (hu)
JP (1) JP3335362B2 (hu)
KR (1) KR100422850B1 (hu)
CN (1) CN1094490C (hu)
AR (1) AR003996A1 (hu)
AT (1) ATE187172T1 (hu)
AU (1) AU715879B2 (hu)
BG (1) BG63779B1 (hu)
BR (1) BR9610579A (hu)
CA (1) CA2228038C (hu)
CO (1) CO4750663A1 (hu)
CZ (1) CZ288149B6 (hu)
DE (1) DE69605430T2 (hu)
DK (1) DK0850235T3 (hu)
EE (1) EE04116B1 (hu)
ES (1) ES2142089T3 (hu)
GR (1) GR3032618T3 (hu)
HK (1) HK1014868A1 (hu)
HU (1) HU222745B1 (hu)
IL (1) IL123600A (hu)
NO (1) NO323841B1 (hu)
NZ (1) NZ318436A (hu)
PL (1) PL184808B1 (hu)
RU (1) RU2167874C2 (hu)
SI (1) SI0850235T1 (hu)
SK (1) SK282222B6 (hu)
TR (1) TR199800464T1 (hu)
UA (1) UA44332C2 (hu)
WO (1) WO1997010238A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3335362B2 (ja) * 1995-09-15 2002-10-15 サノフィ―サンテラボ キノレイン−２（１ｈ）−オン誘導体セロトニンアンタゴニスト
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2761067B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1395575A (zh) 2000-01-20 2003-02-05 卫材株式会社 新的哌啶化合物及其药物
FR2812548B1 (fr) * 2000-08-01 2002-09-20 Sanofi Synthelabo Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
FR2909670B1 (fr) * 2006-12-12 2010-07-30 Sanofi Aventis Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
AU2008297876B2 (en) 2007-09-14 2011-07-07 Addex Pharma S.A. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
ES2424393T3 (es) * 2008-10-02 2013-10-01 Taisho Pharmaceutical Co., Ltd. Derivado de 7-piperidinalquil-3,4-dihidroquinolona
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR102461134B1 (ko) 2014-01-21 2022-10-28 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
JP6974331B2 (ja) 2016-02-05 2021-12-01 デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. 化合物、組成物及び方法
HUE058802T2 (hu) 2016-12-09 2022-09-28 Denali Therapeutics Inc RIPK1 inhibitorokként alkalmas vegyületek
CN108707109A (zh) * 2018-08-29 2018-10-26 常州沃腾化工科技有限公司 一种2-甲氧基-4-三氟甲基吡啶-3-磺酰氯的制备方法
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP3335362B2 (ja) * 1995-09-15 2002-10-15 サノフィ―サンテラボ キノレイン−２（１ｈ）−オン誘導体セロトニンアンタゴニスト

Also Published As

Publication number Publication date
GR3032618T3 (en) 2000-05-31
CO4750663A1 (es) 1999-03-31
WO1997010238A1 (fr) 1997-03-20
NO981141D0 (no) 1998-03-13
ATE187172T1 (de) 1999-12-15
AR003996A1 (es) 1998-09-30
CA2228038A1 (en) 1997-03-20
ES2142089T3 (es) 2000-04-01
BG63779B1 (bg) 2002-12-29
BG102316A (en) 1999-03-31
HK1014868A1 (en) 1999-10-08
NZ318436A (en) 1999-02-25
TR199800464T1 (xx) 1998-05-21
UA44332C2 (uk) 2002-02-15
AU715879B2 (en) 2000-02-10
EP0850235B1 (fr) 1999-12-01
EE04116B1 (et) 2003-08-15
SK34698A3 (en) 1998-08-05
CZ288149B6 (en) 2001-05-16
PL184808B1 (pl) 2002-12-31
KR19990044666A (ko) 1999-06-25
HUP9802940A3 (en) 2001-11-28
JP3335362B2 (ja) 2002-10-15
DE69605430D1 (de) 2000-01-05
SK282222B6 (sk) 2001-12-03
NO323841B1 (no) 2007-07-09
KR100422850B1 (ko) 2004-07-23
EP0850235A1 (fr) 1998-07-01
SI0850235T1 (en) 2000-04-30
AU6991996A (en) 1997-04-01
IL123600A0 (en) 1998-10-30
CA2228038C (en) 2009-04-21
CN1202168A (zh) 1998-12-16
CZ78698A3 (cs) 1998-06-17
JPH11514982A (ja) 1999-12-21
IL123600A (en) 2001-05-20
BR9610579A (pt) 1999-07-06
HU222745B1 (hu) 2003-09-29
RU2167874C2 (ru) 2001-05-27
PL325467A1 (en) 1998-07-20
DK0850235T3 (da) 2000-05-29
CN1094490C (zh) 2002-11-20
US5958924A (en) 1999-09-28
DE69605430T2 (de) 2000-07-13
NO981141L (no) 1998-05-15
MX9802028A (es) 1998-09-30
EE9800089A (et) 1998-10-15

Similar Documents

Publication Publication Date Title
HUP9802940A2 (hu) Kinolin-2(1H)-on-származékok mint szerotoninantagonisták
PL317381A1 (en) Derivatives of quinoline as antagonists of tachykynin receptors nk3
CY2505B1 (en) Quinoline derivatives as nk3 antagonists
IL123581A0 (en) Pyrimidine derivatives as 5HT2c- receptor antagonists
EG21556A (en) Bicyclic amine derivatives
IL124522A0 (en) Quinoline derivatives
GB9623944D0 (en) Bicyclic amine derivatives
GR3036346T3 (en) BENZO[g]QUINOLINE DERIVATIVES
IL128141A0 (en) Tetrahydroquinoline derivatives as eaa antagonists
IL124352A0 (en) Salts of quinoline derivatives as nk3 antagonists
ZA937505B (en) Imidazopyridine derivatives as 5-HT4 receptor antagonists
PL330708A1 (en) Derivatives of indolydine useful as antagonists of 5-ht-2c receptor
AU6923998A (en) Quinoline-2(1h)-one and dihydroquinoline-2(1h)-one derivatives as ligands of 5-ht, 5-ht2 and 5-ht1-like receptors
PL333079A1 (en) Piparazinic derivatives as antagonists of neurokinin
PL330796A1 (en) Derivatives of indolin useful as antagonists of 5-ht-2c receptor
ZA985870B (en) 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives
HK1020569A1 (en) Benzo[g]quinoline derivatives
AU2984695A (en) 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists
ZA957309B (en) New thiazolo[3,2-a]quinoline and -naphthyridine derivatives
PL318106A1 (en) Quinoline derivatives as antagonists of leucotrienes
SI0940391T1 (en) Quinoline derivatives as tachykinin NK3 receptor antagonists
HU9900343D0 (en) Use of quinoline derivatives having tachycinin nk3 receptor antagonist
PL325355A1 (en) Novel derivative of 2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-5-carboxylic n-methylpiperazinylamide
GB9624437D0 (en) Bicyclic amine derivatives
GB9624516D0 (en) Bicyclic amine derivatives

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20030813

MM4A Lapse of definitive patent protection due to non-payment of fees